• ACC2014: Interview with Samir Kapadia, MD

    Ron Waksman, MD, interviews Samir Kapadia, MD, on the high-risk cohort from the U.S. pivotal trial with CoreValve.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details